Vaccine effectiveness study for malaria in young children
Part of Infections clinical trials.
This study looks at how well the R21/Matrix-M malaria vaccine works in real-life settings for children under 5. If your child is eligible for the vaccine and has a fever, they may be able to join and help us understand the vaccine's impact.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is under 5 years old and lives in an area where the malaria vaccine is being given.
- Your child is scheduled to receive the R21/Matrix-M malaria vaccine as part of the national vaccination program.
- Your child has a fever (temperature of at least 37.5°C) or had a fever in the last 24 hours and is being tested for malaria.
- You are 18 or older and can provide written permission for your child to join.
- Your child has not previously received any dose of the RTS,S malaria vaccine (a different malaria vaccine).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a seasonal vaccination schedule with the R21 malaria vaccine to help eliminate malaria in your community. It may be a good fit if you are looking for a way to protect yourself or your child from malaria during peak transmission seasons.
This study tests different doses and forms of a malaria vaccine to see which works best and is safest. It may help protect you from malaria for a full year.
This trial tests a new malaria vaccine in healthy children. It aims to see if the vaccine is safe and how well it works in children who have had their regular childhood shots.
This study checks how well evidence about the RTS,S/AS01 malaria vaccine helps inform health policy. You may be included if you live in a specific local area and your child is the right age for the vaccine schedule, and you agree to participate.
This study looks at whether malaria vaccines can also help lower the risk of a serious bacterial infection called invasive non-typhoidal Salmonella (iNTS). If you have a fever, you may be able to join and help researchers understand this connection.
This trial is testing whether giving a malaria vaccine and a malaria drug together to whole villages in Bangladesh can help stop the spread of malaria and protect the entire community. It is open to nearly everyone living in selected villages, including children and adults.
Hear when a new Malaria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.